Publication:
Design considerations for clinical trials of radiotherapy combined with immunotherapy

dc.contributor.coauthorWelsh, James
dc.contributor.kuauthorSezen, Duygu
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.date.accessioned2024-12-29T09:40:29Z
dc.date.issued2023
dc.description.abstractThe discovery of synergistic effects between radiation and immunotherapy in pre-clinical studies has encouraged researchers to conduct clinical trials testing the effects of combined therapy in patients. The first step in conducting any clinical trial is to define the hypothesis and core objectives. The challenge while developing trials analyzing combinations of immunotherapy and radiation therapy (RT) is to select an appropriate hypothesis that can be tested in the future research, as well as raising new questions for investigation. Here, we review some of the concerns and challenges for designing clinical trials of RT combined with immunotherapy.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyTR Dizin
dc.description.issue1
dc.description.openaccessgold
dc.description.publisherscopeNational
dc.description.volume38
dc.identifier.doi10.5505/tjo.2022.3865
dc.identifier.issn1300-7467
dc.identifier.quartileQ4
dc.identifier.scopus2-s2.0-85149489324
dc.identifier.urihttps://doi.org/10.5505/tjo.2022.3865
dc.identifier.urihttps://hdl.handle.net/20.500.14288/23354
dc.identifier.wos981235700016
dc.keywordsClinical trial
dc.keywordsImmunotherapy
dc.keywordsRadiotherapy
dc.languageen
dc.publisherKare Publ
dc.sourceTürk Onkoloji Dergisi-Turkish Journal of Oncology
dc.subjectOncology
dc.titleDesign considerations for clinical trials of radiotherapy combined with immunotherapy
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorSezen, Duygu

Files